Course Information

Advances in Autism 2022

Live Virtual Learning

April 29, 2022

Download: [ PDF ]

This annual symposium, now virtual, is designed for all those interested in learning about the latest breakthroughs in research and treatment in autism spectrum disorder (ASD), including health care providers, teachers, autism service providers, and families. Nationally renowned UCLA Center for Autism Research and Treatment (CART) faculty and guest speakers will present the most up-to-date information about ASD.

Pre-recorded talks will be available for viewing two weeks before the live event. The symposium will cover topics such as biomarker development in clinical research, the future of autism intervention, up-to-date information about ASD genetics, ASD and motor function, sexuality and gender diversity in neurodiverse youth, and the experience of living with autism during the COVID-19 pandemic.

On Friday, April 29, 2022, a live discussion will be presented along with a Q and A session with the featured speakers. Participants will be able to submit questions while viewing the pre-recorded talks before the event through this website as well as during the day of the live event. To qualify for the 7.5 CME credits for participation in this activity, participants will be required to attend the April 29 live event.

Target Audience

This annual symposium, which this year will include both live and recorded presentations, is designed for all those interested in learning about the latest breakthroughs in research and treatment in autism spectrum disorder (ASD), including health care providers, teachers, autism service providers, self advocates and families.

Course Fees

  • $225 - Physicians and Doctoral Level Professionals
  • $205 - Nurses and Allied Health Professionals
  • $125 - Non-Healthcare

Justice, Equity, Diversity, and Inclusion (JEDI)

UCLA CART has established the JEDI Fund to help support members of the BIPOC community to attend the UCLA CART symposium. Please contact Monica Belli Haley at mbelli@mednet.ucla.edu to learn more. Availability is limited.

Enroll Online

To enroll click here.

Enrollment Deadlines

Note: To ensure course material is received before the course begins, early registration is advised. Online registration will close at 11:59 PM on Tuesday, April 26th.

Enrollment after online registration has closed: Please call (310) 794 – 2620 or email UCLACME@mednet.ucla.edu between 8:00 AM – 5:00 PM (Pacific Standard Time) by Thursday, April 28th .

Enrollment on the day(s) of the course: Registration will only be accepted between 7:00 AM - 10:00 AM (Pacific Standard Time). Please email UCLACME@mednet.ucla.edu to enroll.

Refunds

Cancellations must be received in writing by Friday, April 15, 2022 and will be subject to a $50 processing fee. No refunds will be granted after that date. If, for any reason, the course must be cancelled, discontinued, or rescheduled by the Office of Continuing Medical Education, a full refund will be provided.

Course Chairs
Daniel H. Geschwind, MD, PhD
Gordon & Virginia MacDonald Distinguished Professor
Departments of Neurology, Psychiatry & Human Genetics*
Sr. Associate Dean & Associate Vice Chancellor, Precision Health
Director, Center for Autism Research & Treatment (CART)

Susan Bookheimer, PhD
Joaquin Fuster Professor of Cognitive Neuroscience*
Director, Staglin IMHRO MRI Laboratory
Director, Intellectual & Developmental Disabilities Research Center
Department of Psychiatry & Biobehavioral Sciences
Co-Director, UCLA Center for Autism Research & Treatment (CART)

UCLA Course Faculty
Shulamite Green, PhD
Assistant Professor in Psychiatry & Biobehavioral Sciences*
UCLA Center for Autism Research & Treatment (CART)

Amanda Gulsrud, PhD
Associate Clinical Professor of Psychiatry & Biobehavioral Sciences*
Clinical Director, Child & Adult Neurodevelopmental (CAN) Clinic
UCLA Center for Autism Research & Treatment (CART)

Brandon S. Ito, MD, MPH
Assistant Clinical Professor of Psychiatry*
UCLA Center for Autism Research & Treatment (CART)

Shafali Spurling Jeste, MD
Associate Professor of Psychiatry & Neurology
Chief, Division of Neurology
Co-Director, Neurological Institute
Las Madrinas Chair, Children’s Hospital Los Angeles
Professor, Neurology & Pediatrics
Keck School of Medicine of USC

Connie Kasari, PhD
Distinguished Professor*
Human Development & Psychology GSE&IS
Semel Institute for Neuroscience & Human Behavior
UCLA Center for Autism Research & Treatment (CART)

Elizabeth Laugeson, PsyD
Associate Clinical Professor*
Founder & Director, UCLA PEERS Clinic
Interim Director, UCLA Tarjan Center UCEDD
UCLA Center for Autism Research & Treatment (CART)

Catherine Lord, PhD
George Tarjan Distinguished Professor of Psychiatry & Education*
UCLA Center for Autism Research & Treatment (CART)

James McPartland, PhD
Professor of Child Psychiatry & Psychology
Director, Yale Developmental Disabilities Clinic
Principal Investigator, Autism Biomarkers Consortium for Clinical Trials

Stephen Shore, EdD
Assistant Professor of Special Education
Adelphi University

Rujuta B. Wilson, MD
Assistant Professor of Pediatric Neurology & Psychiatry*
Associate Program Director, Pediatric Neurology
UCLA Center for Autism Research & Treatment (CART)


*David Geffen School of Medicine, UCLA

Friday, April 29, 2022

9:00 AM (PST) Welcome
Daniel H. Geschwind, MD, PhD

Keynote I

9:15 AM Biomarker Development to Improve Clinical Research in Autism
Speaker: James McPartland, PhD
Moderator: Shafali Spurling Jeste, MD

Keynote II

9:45 AM The Next Generation of Intervention Science for Autism
Speaker: Connie Kasari, PhD
Moderator: Amanda C. Gulsrud, PhD
10:15 AM Break

Genetics

10:30 AM Advances in the Genetics of Autism
Speaker: Daniel H. Geschwind, MD, PhD
Moderator: Susan Bookheimer, PhD

Motor

11:00 AM Motor Function in Autism: Research and Clinical Applications
Speaker: Rujuta B. Wilson, MD, MS
Moderator: Shulamite Green, PhD
11:30 AM Break

Sexuality and Autism

11:45 AM Correlations, Controversies, and Clinical Care: Exploring Sexual and Gender Diversity in Neurodiverse Youth
Speaker: Brandon S. Ito, MD, MPH
Moderator: Catherine Lord, PhD

Self-Advocate

12:15 PM Supporting Autistic People in Uncertain Times: Coping and Thriving During the COVID-19 Pandemic
Speaker: Stephen Shore, EdD
Moderator: Elizabeth Laugeson, PsyD
12:45 PM Adjourn
Daniel H. Geschwind, MD, PhD

At the conclusion of this course, participants will be able to:

  • Describe ASD biomarker development in clinical research
  • Inform families of autistic children about the current goals and new approaches to intervention research in ASD
  • Integrate genetics into our understanding of ASD
  • Explore motor function in ASD
  • Review sexual and gender diversity in neurodiverse youth
  • Identify support for autistic people during uncertain times

The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA designates this live activity for a maximum of 7.5 AMA PRA Category 1 Credits TM. Physicians should claim only credit commensurate with the extent of their participation in the activity.

The California State Board of Registered Nursing accepts courses approved by the AMA for category 1 credit as meeting the continuing education requirements for license renewal. Nurses from states other than California should inquire with their local State Board for specific continuing education policies.

The FDA has issued a concept paper which classifies commercial support of scientific and educational programs as promotional unless it can be affirmed that the program is "truly independent" and free of commercial influence. In addition to independence, the FDA requires that nonpromotional, commercially supported education be objective, balanced, and scientifically rigorous. The policy further states that all potential conflicts of interest of the CME staff and faculty be fully disclosed to the program's participants. In addition, Accreditation Council for Continuing Medical Education policy mandates that the provider adequately manages all identified potential conflicts of interest prior to the program. We at UCLA fully endorse the letter and spirit of these concepts.